Triple
T4392524
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | non-Hodgkin lymphoma |
E99398
|
entity |
| Predicate | hasSubtype |
P1244
|
FINISHED |
| Object |
follicular lymphoma
Follicular lymphoma is a typically slow-growing type of B-cell non-Hodgkin lymphoma characterized by cancerous growth of lymphocytes in follicle-like clusters within lymph nodes.
|
E99398
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: follicular lymphoma | Statement: [non-Hodgkin lymphoma, hasSubtype, follicular lymphoma]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: follicular lymphoma Context triple: [non-Hodgkin lymphoma, hasSubtype, follicular lymphoma]
-
A.
non-Hodgkin lymphoma
Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
-
B.
Hodgkin lymphoma
Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
-
C.
Hodgkin
Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
-
D.
R-CHOP
R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
-
E.
B lymphocytes
B lymphocytes are a type of white blood cell central to the adaptive immune system, responsible for producing antibodies and mediating humoral immunity.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: follicular lymphoma Triple: [non-Hodgkin lymphoma, hasSubtype, follicular lymphoma]
Generated description
Follicular lymphoma is a typically slow-growing type of B-cell non-Hodgkin lymphoma characterized by cancerous growth of lymphocytes in follicle-like clusters within lymph nodes.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: follicular lymphoma Target entity description: Follicular lymphoma is a typically slow-growing type of B-cell non-Hodgkin lymphoma characterized by cancerous growth of lymphocytes in follicle-like clusters within lymph nodes.
-
A.
non-Hodgkin lymphoma
chosen
Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
-
B.
Hodgkin lymphoma
Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
-
C.
Hodgkin
Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
-
D.
R-CHOP
R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
-
E.
B lymphocytes
B lymphocytes are a type of white blood cell central to the adaptive immune system, responsible for producing antibodies and mediating humoral immunity.
- F. None of above.
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69b345506b408190b0e3dee616738a7d |
completed | March 12, 2026, 10:59 p.m. |
| NER | Named-entity recognition | batch_69b35285592881909fcdea225a655950 |
completed | March 12, 2026, 11:55 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b5e53385508190ac1261c44672070b |
completed | March 14, 2026, 10:46 p.m. |
| NEDg | Description generation | batch_69b5e666bcbc819083bbb60309d689e7 |
completed | March 14, 2026, 10:51 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69b5e6c780248190a2101f35f47ae374 |
completed | March 14, 2026, 10:52 p.m. |
Created at: March 12, 2026, 11:19 p.m.